In breast cancer, Prevotella copri reduces host IPyA levels and thereby promotes tumor growth via UHRF1 mediated phosphorylation of AMP-activated protein kinase (AMPK) [114]. This evidence concerns the gene UHRF1 and breast carcinoma.